Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:00 pm Sale |
2024-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
TANG CAPITAL PARTNERS LP | 3,296,883 6.300% |
-743,917 (-18.41%) |
Filing History |
| 2024-12-27 4:05 pm Purchase |
2024-12-18 | 13G | ALX Oncology Holdings Inc. ALXO |
HBM BIOVENTURES CAYMAN LTD | 3,426,929 6.500% |
3,426,929 (New Position) |
Filing History |
| 2024-12-06 11:33 am Sale |
2024-11-29 | 13G | ALX Oncology Holdings Inc. ALXO |
FMR CORP | 1,798,875 3.400% |
-4,066,231 (-69.33%) |
Filing History |
| 2024-11-14 7:22 pm Sale |
2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 0 0.000% |
-2,255,000 (Position Closed) |
Filing History |
| 2024-11-14 6:58 pm Purchase |
2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO |
Vivo Capital Fund IX L.P. | 1,813,864 3.400% |
1,813,864 (New Position) |
Filing History |
| 2024-11-14 3:02 pm Sale |
2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO |
Cormorant Asset Management LP | 0 0.000% |
-3,142,079 (Position Closed) |
Filing History |
| 2024-11-12 09:50 am Sale |
2024-11-08 | 13G | ALX Oncology Holdings Inc. ALXO |
FMR CORP | 5,865,106 11.135% |
-1,607,715 (-21.51%) |
Filing History |
| 2024-10-10 4:14 pm Sale |
2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO |
MILLENNIUM MANAGEMENT LLC | 2,002,374 3.800% |
-959,297 (-32.39%) |
Filing History |
| 2024-08-22 4:00 pm Purchase |
2024-08-12 | 13G | ALX Oncology Holdings Inc. ALXO |
TANG CAPITAL PARTNERS LP | 4,040,800 7.700% |
4,040,800 (New Position) |
Filing History |
| 2024-08-13 4:17 pm Purchase |
2024-08-06 | 13G | ALX Oncology Holdings Inc. ALXO |
MILLENNIUM MANAGEMENT LLC | 2,961,671 5.600% |
2,961,671 (New Position) |
Filing History |
| 2024-02-14 7:45 pm Sale |
2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 2,255,000 4.500% |
-11,000 (-0.49%) |
Filing History |
| 2024-02-14 7:28 pm Sale |
2023-12-15 | 13D | ALX Oncology Holdings Inc. ALXO |
LSV Associates LLC | 2,949,580 5.900% |
-1,259,395 (-29.92%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
Redmile Group LLC | 4,909,264 9.600% |
-82,281 (-1.65%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | ALX Oncology Holdings Inc. ALXO |
FMR CORP | 7,472,821 14.999% |
1,359,393 (+22.24%) |
Filing History |
| 2023-12-19 5:38 pm Sale |
2023-12-13 | 13D | ALX Oncology Holdings Inc. ALXO |
LSV Associates LLC | 4,208,975 8.400% |
-512,015 (-10.85%) |
Filing History |
| 2023-10-16 5:15 pm Purchase |
2023-10-04 | 13G | ALX Oncology Holdings Inc. ALXO |
Redmile Group LLC | 4,991,545 9.600% |
4,991,545 (New Position) |
Filing History |
| 2023-10-13 4:00 pm Purchase |
2023-10-03 | 13G | ALX Oncology Holdings Inc. ALXO |
Cormorant Asset Management LP | 3,142,079 6.310% |
3,142,079 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | ALX Oncology Holdings Inc. ALXO |
ORBIMED ADVISORS LLC | 2,266,000 5.600% |
2,266,000 (New Position) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | ALX Oncology Holdings Inc. ALXO |
FMR CORP | 6,113,428 15.000% |
1,832,912 (+42.82%) |
Filing History |
| 2022-08-10 08:10 am Purchase |
2022-08-09 | 13G | ALX Oncology Holdings Inc. ALXO |
FMR CORP | 4,280,516 10.522% |
1,687,577 (+65.08%) |
Filing History |